{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:21:56Z","timestamp":1782602516923,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,21]],"date-time":"2016-11-21T00:00:00Z","timestamp":1479686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ajoc.2017.06.011","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T19:30:23Z","timestamp":1498159823000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Retinal findings in membranoproliferative glomerulonephritis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8430-2214","authenticated-orcid":false,"given":"Ahmad M.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7304-909X","authenticated-orcid":false,"given":"Luiz H.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6104-5737","authenticated-orcid":false,"given":"J. Fernando","family":"Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Hage","family":"Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Bou","family":"Ghannam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2017.06.011_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrneph.2010.85","article-title":"C3 glomerulopathy: a new classification","volume":"6","author":"Fakhouri","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.krcp.2014.07.006","article-title":"Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study","volume":"33","author":"Woo","year":"2014","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.ajoc.2017.06.011_bib3","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ophtha.2016.02.018","article-title":"Manifestations of complement-mediated and immune complex-mediated membranoproliferative glomerulonephritis: a comparative consecutive series","volume":"123","author":"Dalvin","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2017.06.011_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/ICB.0000000000000164","article-title":"Shedding light on fundus drusen associated with membranoproliferative glomerulonephritis: breaking stereotypes of types I, II, and III","volume":"10","author":"Dalvin","year":"2016","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2017.06.011_bib5","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archopht.1997.01100160097022","article-title":"Subretinal fluid associated with membranoproliferative glomerulonephritis","volume":"115","author":"Polk","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0002-9394(14)71397-2","article-title":"Membranoproliferative glomerulonephritis type II associated with central serous retinopathy","volume":"116","author":"Ulbig","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib7","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/bjo.2009.159475","article-title":"Functional and morphological macular abnormalities in membranoproliferative glomerulonephritis type II","volume":"94","author":"Ritter","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.eye.6701897","article-title":"Optical coherence tomography of fundus findings in type II mesangiocapillary glomerulonephritis","volume":"20","author":"Venkatesh","year":"2006","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajoc.2017.06.011_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00006982-200304000-00026","article-title":"Optical coherence tomography of fundus abnormalities associated with type II membranoproliferative glomerulonephritis","volume":"23","author":"Batio\u011flu","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ajoc.2017.06.011_bib10","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/bjo.73.11.900","article-title":"Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic features","volume":"73","author":"Duvall-Young","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bjo.73.4.297","article-title":"Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report","volume":"73","author":"Duvall-Young","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archophthalmol.2009.38","article-title":"Extensive drusen in type I membranoproliferative glomerulonephritis","volume":"127","author":"Han","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjo.2009.178400","article-title":"Angiography features of early onset drusen","volume":"95","author":"Guigui","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/eye.1998.230","article-title":"Marked thickening of Bruch's membrane in a 17-year-old man with angioid streaks","volume":"12","author":"Mansour","year":"1998","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ajoc.2017.06.011_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","article-title":"Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease","volume":"14","author":"Mullins","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.ajoc.2017.06.011_bib16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/ki.2008.658","article-title":"Oligosaccharide composition is similar in drusen and dense deposits in membranoproliferative glomerulonephritis type II","volume":"75","author":"D'Souza","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ajoc.2017.06.011_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bjo.2007.130138","article-title":"Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis","volume":"92","author":"D'Souza","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib18","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1016\/S0272-6386(03)00665-6","article-title":"Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II (\u201cdense deposit disease\u201d)","volume":"42","author":"Colville","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ajoc.2017.06.011_bib19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/archophthalmol.2012.265","article-title":"Clinical evaluation of 3 families with basal laminar drusen caused by novel mutations in the complement factor H gene","volume":"130","author":"van de Ven","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/13816810.2015.1101777","article-title":"Retinal disease in the C3 glomerulopathies and the risk of impaired vision","volume":"37","author":"Savige","year":"2016","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.ajoc.2017.06.011_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF00166300","article-title":"Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients","volume":"229","author":"Leys","year":"1991","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/112067219100100104","article-title":"Sequential observation of fundus changes in patients with long standing membranoproliferative glomerulonephritis type II (MPGN type II)","volume":"1","author":"Leys","year":"1991","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF00918479","article-title":"Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II","volume":"228","author":"Leys","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMc1112273","article-title":"Eculizumab in a patient with dense-deposit disease","volume":"366","author":"Daina","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajoc.2017.06.011_bib25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of dense-deposit disease","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajoc.2017.06.011_bib26","first-page":"273","article-title":"Compstatin: a complement inhibitor on its way to clinical application","volume":"632","author":"Ricklin","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/978-1-4419-5635-4_9","article-title":"Suppression of drusen formation by compstatin, a peptide inhibitor of complement C3 activation, on cynomolgus monkey with early-onset macular degeneration","volume":"703","author":"Chi","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajoc.2017.06.011_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00347-012-2550-y","article-title":"Patient with type II membranoproliferative glomerulonephritis: intravitreal bevacizumab therapy for choroidal neovascularization","volume":"109","author":"Karampelas","year":"2012","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ajoc.2017.06.011_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-010247","article-title":"Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab","author":"McCullagh","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ajoc.2017.06.011_bib30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3928\/15428877-20096030-13","article-title":"Treatment of subretinal neovascular membrane in a patient with membranoproliferative glomerulonephritis type II","volume":"40","author":"Farah","year":"2009","journal-title":"Ophthalmic Surg Lasers Imaging"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993616302821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993616302821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:55:47Z","timestamp":1762527347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993616302821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"alternative-id":["S2451993616302821"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2017.06.011","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal findings in membranoproliferative glomerulonephritis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2017.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}